The CPAP, BiPAP, and ventilator equipment manufactured by Phillips Respironics were the subject of significant complaints, which were addressed for a total of $479 million in the settlement. Significant problems with the safety of medical devices and manufacturing standards are brought to light by this historic class action complaint.
Something missing? Search here.
These problems might affect millions of users who depend on these devices for the treatment of sleep apnea and respiratory conditions. Aside from compensating consumers who were harmed, the settlement also requires adjustments to be made to avoid such events in the future.
$479M Phillips Respironics Class Action Settlement 2024
Phillips Respironics, a medical supply firm owned by Phillips, has agreed to pay a minimum amount of $475 million to reimburse eligible customers who paid for certain ventilator devices, continuous positive airway pressure (CPAP), and bilateral positive airway pressure (BiPAP) devices that are used for sleep apnea and breathing assistance. In addition, Phillips will provide qualifying claims with up to $15 million in “Device Replacement Awards” and up to $34 million in “Payer Awards.”
There are several different sorts of claims and monetary awards that are available to claimants who meet the requirements. Please continue reading to get further information on the various payment kinds.
To date, Philips Respironics has sold or supplied over 10.8 million CPAP, BiPAP, and other devices in the US market. These devices are subject to recall due to defects, and they are included in the $475 Million Class Action Settlement. According to reports from the Food and Drug Administration, medical devices manufactured by Phillips that are used to treat obstructive sleep apnea and other breathing disorders have been responsible for 567 fatalities since April 2021.
The proposed settlement does not cover any claims for personal damage or medical monitoring that that device may cause. This is something that should be taken into consideration. This class action lawsuit is an attempt to address economic damage claims that have arisen as a result of the purchase of Phillips medical equipment that has been impacted.
There is ongoing litigation concerning claims that are associated with medical monitoring or medical injuries. In addition, it is essential to emphasize that you should not discontinue your therapy and should immediately visit your physician if you are using one of the devices that are covered in the Ventilator Class Action Lawsuit.
Lipitor Atorvastatin Pfizer Antitrust
Kia & Hyundai Anti-Theft Class Action
Overview of $479M Phillips Respironics Class Action Settlement 2024
| Claim Name | $479M Phillips Respironics Class Action Settlement – CPAP, PiPAP, Ventilator Devices |
| Country | US |
| Payment Method | Online |
| Post Category | Finance |
Eligibility details
Everyone who lives in the US (including its territories and DC) and has bought, rented, or leased a qualifying medical device, or who has gotten a prescription for one, or who has had money taken out of their pay check to buy, rent, or pay for a Recalled Device—everyone falls into the Settlement Class. Insurance companies, self-funded employers, and third-party payers all fall under this group. A user may earn one of four distinct sorts of Awards:
To be eligible for the Device Payment Award, consumers must have not yet returning their Returned Equipment to Philips Respironics and must either not intend to return it or cannot return it.
The Device Return Award is available to registered consumers who want to send back their Recalled Device to Philips Respironics.
The Device Replacement Awards are a way for consumers to get their money back if they’ve already bought, leased, or rented a comparable replacement for a Recalled Device.
Payer Awards are intended for customers who have refunded (in whole or in part) their payments for a Philips Respironics Returned Equipment.
Please be aware that if you have received replacement equipment at any point in time following the 2021 CPAP, BiPAP, Ventilator Phillips recall, then that device is NOT eligible, even if the serial number of the device shows it as possibly eligible.
You are welcome to get in touch with the Class Action Settlement Administrator if you are unsure as to whether or not you are a representative of this Settlement:
Please call us at this number: 1-855-912-3432.
Messages may be sent to [email protected].
What is the maximum amount that I may get paid?
If you are a participant in a class action lawsuit that meets the requirements, you could be entitled to a Device Payment Award for each Recalled Device that you have bought, leased, or rented. It is dependent on the particular model of your Recalled Device as to how much of a prize you will receive.
For every recall device that you can return or have already returned, you can be eligible for a Device Return Award of one hundred dollars. The deadline to submit the claim form is August 9th, 2024. It is possible that the particular model of the Recalled Device will not have any impact on the amount of the Device Return Award you get.
If you spend money to replace a Recalled Device on or after June 14, 2021, and before September 7, 2023, you may be entitled to a Device Replacement Award. This award is for the expenses that you incurred. In addition to the Device Payment Award of one hundred dollars for your Recalled Device, this payment will also be made. You needed to buy the Replacement Device either before you got a Remanufactured Device from Philips Respironics or without getting one to be eligible for the program.
The $34 million fund may provide you with the opportunity to receive a Payer Award. Payer Awards are going to be determined at a later time by the administrator of the Phillips Class Action Settlement. Please save this website to your bookmarks or come back to it for updates.
How Do I File a Claim?
You need to submit a proper claim form to be eligible to receive a payout from the Phillips Devices Recall Class Action. Links to the claim forms may be found below. The date of August 9, 2024, is the cutoff for submitting a claim.
According to the timetable, the final hearing before the court to obtain approval of the settlement will take place on April 11, 2024. Please be sure you check this page frequently for any prospective revisions since the dates and deadlines for court proceedings are subject to change.
The Upcoming Updates
It is anticipated that Phillips Respironics will release new designs for its continuous positive airway pressure (CPAP), biphasic pulmonary artery (BiPAP), and ventilator devices. These designs will include more sophisticated safety measures and materials that are more dependable.
iPhone Class Action Settlement
Audits and Compliance Checks Conducted regularly: To guarantee that the new safety requirements are adhered to continually and to address any new problems as soon as they arise, regular audits and compliance checks will be implemented.
Integration of User Feedback It is anticipated that future upgrades to the devices will place a greater focus on user feedback to effectively detect and promptly address any possible issues that may arise.
Investments in research and development may result in the creation of innovative technologies that improve the efficiency and safety of respiratory care equipment. These technologies might be introduced as a result of innovative technologies.
Final Thoughts
A huge step forward in the medical device business, the $479 million Phillips Respironics class action settlement addresses important safety issues for millions of users. This is a big accomplishment. It ensures that injured persons get the required compensation while also enforcing more stringent safety practices and quality requirements.
| Home Page | https://baltimoreoutloud.com/wp/ |
In addition to serving as a reminder of the critical function that regulatory authorities play in the process of safeguarding the general public’s health, this case highlights the significance of stringent testing and supervision in the production of medical devices. It is anticipated that future upgrades to the products and processes of Phillips Respironics will improve the safety and effectiveness of the device, which will be to the advantage of users as well as the larger healthcare community.
Calista Embry is a finance journalist who graduated from Johns Hopkins University. She has a passion for writing and researching the impact of finance on social life.
Something missing? Search here.